Trial intelligence / Profile preview

Allergovit in Seasonal Allergic Rhinitis

NCT01475188Phase 4Completed

Sponsor
Ministerstwo Nauki i Szkolnictwa Wyższego
Start
Mar 2007
Primary completion
Oct 2010
Modality
Peptides, Peptide-based Cancer Vaccines, Allergy Immunotherapy
Countries
1
01

Overview

A Phase 4 trial of Allergovit in seasonal allergic rhinitis (SAR), sponsored by Ministerstwo Nauki i Szkolnictwa Wyższego. Started Mar 2007; status: completed.

02

Drugs

Allergovit
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT01475188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01475188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call